The Impact of the ACA: How Readmission Penalties Will Affect the Healthcare Executive’s Mission (See #64 for description)- 1.5 type I face-to-face credits
- Jordan Wathen, Director of Finance
- M. Hunter Perry, Director of Transitional Care Mgmt., Baptist
Aligning Evidence-Based Design and Evidence-Based Medicine to Design a More Efficient and Higher Quality Patient-Centered Healthcare Delivery Model (see #67 for description)- 1.5 type I face-to-face credits
- Emily Volk, MD
- Mary Ann Ursua Wilkins, FACHE, Director of Family Practice, CHRISTUS
More info to come on our Eventbrite registration site soon!
November 9, 2016: Well, that was quite an election cycle with shocking results for many. So, where do we go from here? How do we take what has been a divisive environment and unify a country to set sights on a clear vision for the future? Or can we? Are we talking transformation here or will it be business as usual? [Read the entire blog post here]
I read an article recently entitled, “VIP Syndrome can be a risk in caring for stars.” It talked about the death of Prince and Michael Jackson, and how special medical care put them in a position to depend on treatment that was considered outside the standard of care and dangerous. Most had to do with the treatment of pain, but it mostly concerned the prescribing and delivery of pain medication such as fentanyl, and the anesthetic propofol, used in Michael Jackson’s case to ease his pain and help him sleep. [Read the full blog post here]
2017 PROPOSED SLATE of New STC-ACHE4
Here is the proposed slate of officers and directors, starting their terms in 2017. If you wish to nominate anyone for the positions listed, please follow the instructions on the bottom of the attachment. Contact us if you have any questions!